首页 | 本学科首页   官方微博 | 高级检索  
     


Immunohistochemical Validation and Expression Profiling of NKG2D Ligands in a Wide Spectrum of Human Epithelial Neoplasms
Authors:Hiromi Fujita  Yutaka Hatanaka  Yoichi Sutoh  Yuta Suzuki  Koji Oba  Kanako C. Hatanaka  Tomoko Mitsuhashi  Noriyuki Otsuka  Kazunori Fugo  Masanori Kasahara  Yoshihiro Matsuno
Affiliation:Department of Surgical Pathology (HF, YH, YS, KCH, TM, YM), Hokkaido University Hospital, Sapporo, Japan;Translational Research and Clinical Trial Center (KO), Hokkaido University Hospital, Sapporo, Japan;Department of Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan (HF, YS, NO, KF, MK)
Abstract:The MHC class I-chain-related proteins (MICs) and the UL16-binding proteins (ULBPs) are inducible stress response molecules that work as activators of a specific receptor, NKG2D, which is expressed on effector cells, such as NK cells and subsets of T cells. In this study, we sought to explore the biological significance of NKG2D ligands in human neoplasms by comprehensively examining the immunohistochemical expression profile of NKG2D ligands in a variety of human epithelial neoplasms. Following careful validation of the immunohistochemical specificity and availability of anti-human ULBP antibodies for formalin-fixed paraffin-embedded (FFPE) materials, the expression of NKG2D ligands was analyzed in FFPE tissue microarrays comprising 22 types of epithelial neoplastic tissue with their non-neoplastic counterpart from various organs. Hierarchical cluster analysis demonstrated a positive relationship among ULBP2/6, ULBP3, ULBP1, and ULBP5, whose expression patterns were similar across all of the neoplastic tissues examined. In contrast, MICA/B, as well as ULBP4, did not appear to be related to any other ligand. These expression profiles of NKG2D ligands in human neoplasms based on well-validated specific antibodies, followed by hierarchical cluster analysis, should help to clarify some functional aspects of these molecules in cancer biology, and also provide a path to the development of novel tumor-type-specific treatment strategies.
Keywords:NKG2D ligands   immunohistochemistry   epithelial neoplasms
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号